FNY Investment Advisers LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

FNY Investment Advisers LLC acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 29,638 shares of the pharmacy operator's stock, valued at approximately $331,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Curat Global LLC acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $27,000. Sentry Investment Management LLC acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $27,000. Riverview Trust Co grew its holdings in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,590 shares during the period. Colonial Trust Co SC grew its holdings in Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares during the period. Finally, Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock remained flat at $11.39 during trading on Thursday. 4,933,878 shares of the stock were exchanged, compared to its average volume of 20,739,101. The firm's 50 day moving average is $11.13 and its two-hundred day moving average is $10.71. The company has a current ratio of 0.61, a quick ratio of 0.32 and a debt-to-equity ratio of 0.92. The stock has a market capitalization of $9.86 billion, a P/E ratio of -1.70, a price-to-earnings-growth ratio of 1.37 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $16.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 3.80% and a positive return on equity of 16.39%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.20 earnings per share. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Insiders Place Their Bets

In other news, Chairman Stefano Pessina purchased 832,258 shares of the company's stock in a transaction on Sunday, April 27th. The shares were purchased at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 17.50% of the company's stock.

Analyst Ratings Changes

WBA has been the subject of several research analyst reports. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.